TY - JOUR

T1 - Scientific Opinion on the substantiation of a health claim related to Teestar™, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses pursuant to Article 13(5) of Regulation (EC) No 1924/2006

AU - EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)

AU - Tetens, Inge

AU - Sjödin, Anders Mikael

PY - 2015

Y1 - 2015

N2 - Following an application from Avesthagen Limited, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Teestar™ and a reduction of post-prandial glycaemic responses. The Panel considers that the food, Teestar™, a fenugreek seed extract standardised by its content of galactomannan, is sufficiently characterised. A reduction of post-prandial glycaemic responses might be a beneficial physiological effect. The applicant submitted one unpublished and eight published human studies as being pertinent to the health claim. No conclusions can be drawn from the eight published studies, as they were not carried out with Teestar™ or any other fenugreek seed extract which complied with the specifications of the food which is the subject of the claim. In one unpublished study, the consumption of Teestar™ did not lead to a reduction in mean peak post-prandial blood glucose concentrations, which was the primary endpoint of the study. The Panel concludes that a cause and effect relationship has not been established between the consumption of Teestar™, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses.

AB - Following an application from Avesthagen Limited, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of France, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver an opinion on the scientific substantiation of a health claim related to Teestar™ and a reduction of post-prandial glycaemic responses. The Panel considers that the food, Teestar™, a fenugreek seed extract standardised by its content of galactomannan, is sufficiently characterised. A reduction of post-prandial glycaemic responses might be a beneficial physiological effect. The applicant submitted one unpublished and eight published human studies as being pertinent to the health claim. No conclusions can be drawn from the eight published studies, as they were not carried out with Teestar™ or any other fenugreek seed extract which complied with the specifications of the food which is the subject of the claim. In one unpublished study, the consumption of Teestar™ did not lead to a reduction in mean peak post-prandial blood glucose concentrations, which was the primary endpoint of the study. The Panel concludes that a cause and effect relationship has not been established between the consumption of Teestar™, a fenugreek seed extract standardised by its content of galactomannan, and a reduction of post-prandial glycaemic responses.

KW - Faculty of Science

KW - Teestar™

KW - Trigonella foenum-graecum

KW - Fenugreek

KW - Post-prandial glycaemic responses

KW - Health claims

U2 - 10.2903/j.efsa.2015.3952

DO - 10.2903/j.efsa.2015.3952

M3 - Journal article

JO - E F S A Journal

JF - E F S A Journal

SN - 1831-4732

M1 - 3952

ER -